CTMX 2.10 ▼ -0.94% Live Trading Data - Stocknear

CytomX Therapeutics Inc.

NASDAQ: CTMX · Real-Time Price · USD
2.10
-0.02 (-0.94%)
At close: Sep 04, 2025, 3:59 PM
2.08
-1.15%
Pre-market: Sep 05, 2025, 09:19 AM EDT
-0.94%
Bid 1.53
Market Cap 346.32M
Revenue (ttm) 141.1M
Net Income (ttm) 47.98M
EPS (ttm) 0.5
PE Ratio (ttm) 4.2
Forward PE -6.84
Analyst Buy
Ask 2.59
Volume 2,395,818
Avg. Volume (20D) 2,623,112
Open 2.14
Previous Close 2.12
Day's Range 2.02 - 2.15
52-Week Range 0.40 - 3.10
Beta 2.13

About CTMX

undefined

Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol CTMX
Website n/a
Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for CTMX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Next Earnings Release

CytomX Therapeutics Inc. is scheduled to release its earnings on Nov 6, 2025, during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
3 weeks ago
+11.9%
CytomX Therapeutics shares are trading higher afte... Unlock content with Pro Subscription
3 months ago
+4.93%
CytomX Therapeutics shares are trading higher after the company announced it dosed its first patient in the Phase 1 study of CX-801 plus KEYTRUDA.